Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function
Manon Duquenne, Cintia Folgueira, Cyril Bourouh, Marion Millet, Anisia Silva, Jérôme Clasadonte, Monica Imbernon, Daniela Fernandois, Ines Martinez-Corral, Soumya Kusumakshi, Emilie Caron, S Rasika, Eleonora Deliglia, Nathalie Jouy, Asturo Oishi, Massimiliano Mazzone, Eric Trinquet, Jan Tavernier, Young-Bum Kim, Stéphane Ory
- Univ. Lille
- Inserm
- CHU Lille
- Laboratory of Development and Plasticity of the Neuroendocrine Brain
- Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria
- AstraZeneca Global Medical Affairs, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn)
- University Santiago de Compostela
- Institut Pasteur de Lille
- CNRS
- AstraZeneca France, Rueil Malmaison, France.
- Centre National de la Recherche Scientifique
- Université de Strasbourg
- Institut des Neurosciences Cellulaires et Intégratives
- Institut Cochin
- Universität Paris V
- Department of Experimental Pharmacology and Toxicology
- Albert-Ludwigs-Universität Freiburg
- Universität des Saarlandes
- Flow Cytometry Core Facility
- BioImaging Center of Lille
- Laboratory of Tumor Inflammation and Angiogenesis
- University of California, Irvine
- Cisbio Bioassays
- Parc Technologique Marcel Boiteux
- Codolet
- VIB-UGent Center for Medical Biotechnology
- Division of Endocrinology
- Diabetes Research Center (Diabetes Unit)
- Metabolism Initiative
- Beth Israel Deaconess Medical Center and Harvard Medical School
127
Link öffnet neuen Tab
Zitate (Scopus)